Novel reaction to new cystic fibrosis medication Trikafta

Novel reaction to new cystic fibrosis medication Trikafta

Abstract We present a novel case of an urticaria multiforme‐type drug reaction to the new cystic fibrosis medication Trikafta (elexacaftor + tezacaftor + ivacaftor). Equipped with this information, clinicians may be more prepared to counsel and treat patients if they experience similar symptoms afte...

Full description

Bibliographic Details
Main Authors: Julian Stashower, Patrick Carr, Virginia Miller, Barrett Zlotoff
Format: Article
Language:English
Published: Wiley 2021-05-01
Series:Clinical Case Reports
Subjects:
cystic fibrosis
drug rash
Trikafta
urticaria
urticaria multiforme
Online Access:https://doi.org/10.1002/ccr3.4116
Description
Summary:Abstract We present a novel case of an urticaria multiforme‐type drug reaction to the new cystic fibrosis medication Trikafta (elexacaftor + tezacaftor + ivacaftor). Equipped with this information, clinicians may be more prepared to counsel and treat patients if they experience similar symptoms after beginning Trikafta.
ISSN:2050-0904

Similar Items